UPDATE 1-BeiGene drug wins U.S. FDA approval for rare form of lymphoma
November 14, 2019 at 16:01 PM EST
The U.S. Food and Drug Administration on Thursday approved BeiGene Ltd's lymphoma treatment, validating the China-based drugmaker's strategy of largely using data from trials held outside the United States to file for approval.